Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases

References

• Friedenstein AJ, Piatetzky S II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 16: 381–90
   PubMedGoogle Scholar
• Gerson SL. Mesenchymal stem cells: no longer second class marrow citizens. Nat Med 1999; 5: 262–4
   PubMed Web of Science ®Google Scholar
• Herzog EL, Chai L, Krause DS. Plasticity of bone marrow derived stem cells. Blood 2003; 102: 3483–93
   PubMed Web of Science ®Google Scholar
• Kassem M. Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells 2004; 6: 369–74
   PubMedGoogle Scholar
• Bruder SP, Kurth AA, Shea M, et al. Bone regeneration by implantation of purified, culture- expanded human mesenchymal stem cells. J Orthop Res 1998; 16: 155–62
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Gordon PL, Koo WKK, et al. Isolated allogenic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932–7
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Koc ON, Devine SM, et al. Co-transplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transpl 2005; 11: 389–98
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11–20
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–41
   PubMed Web of Science ®Google Scholar
• Mareschi K, Ferrero I, Rustichelli D, et al. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 2006; 97: 744–54
   PubMed Web of Science ®Google Scholar
• Brunstein C, Verfaillie CM. The Hematopoietic Microenvironment. Thomas’ Hematopoitic Cell Transplantation3rd edition, CG Blume, SG Forman, FR Appelbaum. Blackwell Publishing, Massachusetts 2004; 53–61
   Google Scholar
• Lecoeur H, Ledru E, Prevost M-C, et al. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin V and 7-AAD cytofluorometric staining methods. J Immunol 1997; 209: 111–23
   Google Scholar
• Horwitz EM. MSC: a coming age in regenerative medicine. Cytotherapy 2006; 8: 194–5
   PubMed Web of Science ®Google Scholar
• Baxter MA, Wynn RF, Jowitt SN, et al. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004; 22: 675–82
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Andreef M, Frassoni F. Mesenchymal stromal cells. Biol Blood Marrow Transpl 2007; 13: 53–7
   Web of Science ®Google Scholar
• Tirode F, Laud-Duval K, Prieur A, et al. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 2007; 11: 421–9
   PubMed Web of Science ®Google Scholar
• Corre J, Mahtouk K, Attal M, et al. Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia 2007; 21: 1079–88
   PubMed Web of Science ®Google Scholar
• Arnulf B, Lecourt S, Soulier J, et al. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia 2007; 21: 158–63
   PubMed Web of Science ®Google Scholar
• Corazza F, Hermans C, Ferster A, et al. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children. Pediatr Res 2004; 55: 152–8
   PubMed Web of Science ®Google Scholar
• Schmidmaier R, Baumann P, Emmerich B, et al. Evaluation of chemosensitivity of human bone marrow stromal cells: differences between common chemotherapeutic drugs. Anticancer Res 2006; 26: 347–50
   PubMed Web of Science ®Google Scholar
• Li J, Law HKW, Lau YL, et al. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol 2004; 127: 326–34
   PubMed Web of Science ®Google Scholar
• Mueller LP, Luetzkendorf J, Mueller T, et al. Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction. Stem Cells 2006; 24: 2753–65
   PubMed Web of Science ®Google Scholar
• Tremain N, Korkko J, Ibberson D, et al. MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells 2001; 19: 408–18
   PubMed Web of Science ®Google Scholar
• Seshi B, Kumar S, King D. Multilineage gene expression in human bone marrow stromal cells as evidenced by single-cell microarray analysis. Blood Cells Mol Dis 2003; 31: 268–85
   PubMed Web of Science ®Google Scholar